{
    "2019-07-16": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Alkermes to Include Bipolar I Disorder in ALKS 3831 NDA",
                "features": {
                    "keywords": [
                        "Alkermes",
                        "Bipolar I Disorder",
                        "ALKS 3831",
                        "NDA"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Here's a Prescription for Eli Lilly Stock: Don't Swallow Yet",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Stock",
                        "Prescription"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Jim Cramer Weighs In On Marvell, General Motors And More",
                "features": {
                    "keywords": [
                        "Jim Cramer",
                        "Marvell",
                        "General Motors"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "automobiles"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}